Global Triple-Negative Breast Cancer Treatment Market Research Report 2023

Report ID: 1969928 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Triple-Negative Breast Cancer Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Alkylating Agents
        1.2.3 Plant Products
        1.2.4 Microorganism Products
        1.2.5 Antimetabolites
        1.2.6 Microtubule Stablizing Agents
    1.3 Market by Application
        1.3.1 Global Triple-Negative Breast Cancer Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Triple-Negative Breast Cancer Treatment Market Perspective (2017-2028)
    2.2 Triple-Negative Breast Cancer Treatment Growth Trends by Region
        2.2.1 Triple-Negative Breast Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Triple-Negative Breast Cancer Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Triple-Negative Breast Cancer Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Triple-Negative Breast Cancer Treatment Market Dynamics
        2.3.1 Triple-Negative Breast Cancer Treatment Industry Trends
        2.3.2 Triple-Negative Breast Cancer Treatment Market Drivers
        2.3.3 Triple-Negative Breast Cancer Treatment Market Challenges
        2.3.4 Triple-Negative Breast Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Triple-Negative Breast Cancer Treatment Players by Revenue
        3.1.1 Global Top Triple-Negative Breast Cancer Treatment Players by Revenue (2017-2022)
        3.1.2 Global Triple-Negative Breast Cancer Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Triple-Negative Breast Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Triple-Negative Breast Cancer Treatment Revenue
    3.4 Global Triple-Negative Breast Cancer Treatment Market Concentration Ratio
        3.4.1 Global Triple-Negative Breast Cancer Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Triple-Negative Breast Cancer Treatment Revenue in 2021
    3.5 Triple-Negative Breast Cancer Treatment Key Players Head office and Area Served
    3.6 Key Players Triple-Negative Breast Cancer Treatment Product Solution and Service
    3.7 Date of Enter into Triple-Negative Breast Cancer Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Triple-Negative Breast Cancer Treatment Breakdown Data by Type
    4.1 Global Triple-Negative Breast Cancer Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Triple-Negative Breast Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Triple-Negative Breast Cancer Treatment Breakdown Data by Application
    5.1 Global Triple-Negative Breast Cancer Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Triple-Negative Breast Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Triple-Negative Breast Cancer Treatment Market Size (2017-2028)
    6.2 North America Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022)
    6.3 North America Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Triple-Negative Breast Cancer Treatment Market Size (2017-2028)
    7.2 Europe Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022)
    7.3 Europe Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Triple-Negative Breast Cancer Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Triple-Negative Breast Cancer Treatment Market Size (2017-2028)
    9.2 Latin America Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022)
    9.3 Latin America Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Triple-Negative Breast Cancer Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Celgene
        11.1.1 Celgene Company Detail
        11.1.2 Celgene Business Overview
        11.1.3 Celgene Triple-Negative Breast Cancer Treatment Introduction
        11.1.4 Celgene Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022)
        11.1.5 Celgene Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Triple-Negative Breast Cancer Treatment Introduction
        11.2.4 Roche Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022)
        11.2.5 Roche Recent Development
    11.3 Immunomedics GmbH
        11.3.1 Immunomedics GmbH Company Detail
        11.3.2 Immunomedics GmbH Business Overview
        11.3.3 Immunomedics GmbH Triple-Negative Breast Cancer Treatment Introduction
        11.3.4 Immunomedics GmbH Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022)
        11.3.5 Immunomedics GmbH Recent Development
    11.4 Merck & Co., Inc.
        11.4.1 Merck & Co., Inc. Company Detail
        11.4.2 Merck & Co., Inc. Business Overview
        11.4.3 Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Introduction
        11.4.4 Merck & Co., Inc. Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022)
        11.4.5 Merck & Co., Inc. Recent Development
    11.5 F. Hoffmann-La Roche Ltd
        11.5.1 F. Hoffmann-La Roche Ltd Company Detail
        11.5.2 F. Hoffmann-La Roche Ltd Business Overview
        11.5.3 F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Introduction
        11.5.4 F. Hoffmann-La Roche Ltd Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022)
        11.5.5 F. Hoffmann-La Roche Ltd Recent Development
    11.6 Eisai Co., Ltd
        11.6.1 Eisai Co., Ltd Company Detail
        11.6.2 Eisai Co., Ltd Business Overview
        11.6.3 Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Introduction
        11.6.4 Eisai Co., Ltd Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022)
        11.6.5 Eisai Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Triple-Negative Breast Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Alkylating Agents
    Table 3. Key Players of Plant Products
    Table 4. Key Players of Microorganism Products
    Table 5. Key Players of Antimetabolites
    Table 6. Key Players of Microtubule Stablizing Agents
    Table 7. Global Triple-Negative Breast Cancer Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Triple-Negative Breast Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Triple-Negative Breast Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Triple-Negative Breast Cancer Treatment Market Share by Region (2017-2022)
    Table 11. Global Triple-Negative Breast Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Triple-Negative Breast Cancer Treatment Market Share by Region (2023-2028)
    Table 13. Triple-Negative Breast Cancer Treatment Market Trends
    Table 14. Triple-Negative Breast Cancer Treatment Market Drivers
    Table 15. Triple-Negative Breast Cancer Treatment Market Challenges
    Table 16. Triple-Negative Breast Cancer Treatment Market Restraints
    Table 17. Global Triple-Negative Breast Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Triple-Negative Breast Cancer Treatment Market Share by Players (2017-2022)
    Table 19. Global Top Triple-Negative Breast Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Triple-Negative Breast Cancer Treatment as of 2021)
    Table 20. Ranking of Global Top Triple-Negative Breast Cancer Treatment Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Triple-Negative Breast Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Triple-Negative Breast Cancer Treatment Product Solution and Service
    Table 24. Date of Enter into Triple-Negative Breast Cancer Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Triple-Negative Breast Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Triple-Negative Breast Cancer Treatment Revenue Market Share by Type (2017-2022)
    Table 28. Global Triple-Negative Breast Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Triple-Negative Breast Cancer Treatment Revenue Market Share by Type (2023-2028)
    Table 30. Global Triple-Negative Breast Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Triple-Negative Breast Cancer Treatment Revenue Market Share by Application (2017-2022)
    Table 32. Global Triple-Negative Breast Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Triple-Negative Breast Cancer Treatment Revenue Market Share by Application (2023-2028)
    Table 34. North America Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Triple-Negative Breast Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Triple-Negative Breast Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Triple-Negative Breast Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Triple-Negative Breast Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Celgene Company Detail
    Table 45. Celgene Business Overview
    Table 46. Celgene Triple-Negative Breast Cancer Treatment Product
    Table 47. Celgene Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 48. Celgene Recent Development
    Table 49. Roche Company Detail
    Table 50. Roche Business Overview
    Table 51. Roche Triple-Negative Breast Cancer Treatment Product
    Table 52. Roche Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 53. Roche Recent Development
    Table 54. Immunomedics GmbH Company Detail
    Table 55. Immunomedics GmbH Business Overview
    Table 56. Immunomedics GmbH Triple-Negative Breast Cancer Treatment Product
    Table 57. Immunomedics GmbH Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 58. Immunomedics GmbH Recent Development
    Table 59. Merck & Co., Inc. Company Detail
    Table 60. Merck & Co., Inc. Business Overview
    Table 61. Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Product
    Table 62. Merck & Co., Inc. Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 63. Merck & Co., Inc. Recent Development
    Table 64. F. Hoffmann-La Roche Ltd Company Detail
    Table 65. F. Hoffmann-La Roche Ltd Business Overview
    Table 66. F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Product
    Table 67. F. Hoffmann-La Roche Ltd Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 68. F. Hoffmann-La Roche Ltd Recent Development
    Table 69. Eisai Co., Ltd Company Detail
    Table 70. Eisai Co., Ltd Business Overview
    Table 71. Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Product
    Table 72. Eisai Co., Ltd Revenue in Triple-Negative Breast Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 73. Eisai Co., Ltd Recent Development
    Table 74. Research Programs/Design for This Report
    Table 75. Key Data Information from Secondary Sources
    Table 76. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Triple-Negative Breast Cancer Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Alkylating Agents Features
    Figure 3. Plant Products Features
    Figure 4. Microorganism Products Features
    Figure 5. Antimetabolites Features
    Figure 6. Microtubule Stablizing Agents Features
    Figure 7. Global Triple-Negative Breast Cancer Treatment Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Triple-Negative Breast Cancer Treatment Report Years Considered
    Figure 11. Global Triple-Negative Breast Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Triple-Negative Breast Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Triple-Negative Breast Cancer Treatment Market Share by Region: 2021 VS 2028
    Figure 14. Global Triple-Negative Breast Cancer Treatment Market Share by Players in 2021
    Figure 15. Global Top Triple-Negative Breast Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Triple-Negative Breast Cancer Treatment as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Triple-Negative Breast Cancer Treatment Revenue in 2021
    Figure 17. North America Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Triple-Negative Breast Cancer Treatment Market Share by Country (2017-2028)
    Figure 19. United States Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Triple-Negative Breast Cancer Treatment Market Share by Country (2017-2028)
    Figure 23. Germany Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Triple-Negative Breast Cancer Treatment Market Share by Region (2017-2028)
    Figure 31. China Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Triple-Negative Breast Cancer Treatment Market Share by Country (2017-2028)
    Figure 39. Mexico Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Triple-Negative Breast Cancer Treatment Market Share by Country (2017-2028)
    Figure 43. Turkey Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Triple-Negative Breast Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Celgene Revenue Growth Rate in Triple-Negative Breast Cancer Treatment Business (2017-2022)
    Figure 46. Roche Revenue Growth Rate in Triple-Negative Breast Cancer Treatment Business (2017-2022)
    Figure 47. Immunomedics GmbH Revenue Growth Rate in Triple-Negative Breast Cancer Treatment Business (2017-2022)
    Figure 48. Merck & Co., Inc. Revenue Growth Rate in Triple-Negative Breast Cancer Treatment Business (2017-2022)
    Figure 49. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Triple-Negative Breast Cancer Treatment Business (2017-2022)
    Figure 50. Eisai Co., Ltd Revenue Growth Rate in Triple-Negative Breast Cancer Treatment Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Celgene
Roche
Immunomedics GmbH
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
Eisai Co., Ltd
Frequently Asked Questions
Triple-Negative Breast Cancer Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Triple-Negative Breast Cancer Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Triple-Negative Breast Cancer Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Smart Water Product

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More